Measles-containing-vaccine second-dose (MCV2) immunization coverage in Pakistan
Pakistan: Measles-containing-vaccine second-dose (MCV2) immunization coverage was 83.0% in 2025. ◆ Volatile
Measles-containing-vaccine second-dose (MCV2) immunization coverage in Pakistan, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
Pakistan recorded 83.0% for measles-containing-vaccine second-dose (mcv2) immunization coverage in 2025. That is the highest value across all 26 years on record.
That represents a change of up 1.2% on the previous year and up 53.7% over ten years.
Over the whole period, measles-containing-vaccine second-dose (mcv2) immunization coverage in Pakistan peaked at 83.0% in 2025 and was at its lowest, 0.0%, in 2000.
That places Pakistan 100th out of 194 countries with data for 2025, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Measles-containing-vaccine second-dose (MCV2) immunization coverage in Pakistan, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 0.0% | — |
| 2006 | 0.0% | — |
| 2007 | 0.0% | — |
| 2008 | 0.0% | — |
| 2009 | 30.0% | — |
| 2010 | 34.0% | +13.3% |
| 2011 | 38.0% | +11.8% |
| 2012 | 42.0% | +10.5% |
| 2013 | 43.0% | +2.4% |
| 2014 | 48.0% | +11.6% |
| 2015 | 54.0% | +12.5% |
| 2016 | 67.0% | +24.1% |
| 2017 | 67.0% | +0.0% |
| 2018 | 67.0% | +0.0% |
| 2019 | 74.0% | +10.4% |
| 2020 | 77.0% | +4.1% |
| 2021 | 79.0% | +2.6% |
| 2022 | 79.0% | +0.0% |
| 2023 | 80.0% | +1.3% |
| 2024 | 82.0% | +2.5% |
| 2025 | 83.0% | +1.2% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 3.0% | 0.0% | 30.0% | 10 |
| 2010s | 53.4% | 34.0% | 74.0% | 10 |
| 2020s | 80.0% | 77.0% | 83.0% | 6 |
Countries ranked near Pakistan
More health data for Pakistan
- Un projection of annual infant deaths, annual growth rate -2.14 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.8219 % change on previous year (2090)
- Heat deaths vs projected death rates 944.5 (2090)
- Un projection of annual infant deaths 55,286 (2100)
- Population ages 65 and above, total, annual growth rate 3.5 % change on previous year (2025)
- Population ages 65 and above, total, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 65 and above, total, per capita 0.0436 units per person (2025)
- Population, female, annual growth rate 1.67 % change on previous year (2025)
- Population, female, per unit of GDP 0.0003 units per US$ of GDP (2025)
- Population, female, per capita 0.4933 units per person (2025)
Frequently asked questions
- What is measles-containing-vaccine second-dose (mcv2) immunization coverage in Pakistan?
- Measles-containing-vaccine second-dose (mcv2) immunization coverage in Pakistan was 83.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Pakistan?
- The highest recorded value was 83.0% in 2025.
- What is the lowest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Pakistan?
- The lowest recorded value was 0.0% in 2000.
- How does Pakistan rank for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- Pakistan ranks 100th out of 194 countries with data for 2025.
- Is measles-containing-vaccine second-dose (mcv2) immunization coverage rising or falling in Pakistan?
- Over the last ten years it is up 53.7%. The long-run trend across the full record is volatile.
- Where does this Pakistan data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).